Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study. [PDF]
Tison A +17 more
europepmc +1 more source
Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway. [PDF]
Tengesdal S +5 more
europepmc +1 more source
Giant Cell Arteritis/Polymyalgia Rheumatica and Atypical Pulmonary Carcinoid Tumor: A Paraneoplastic Syndrome? [PDF]
Al Tabaa O +5 more
europepmc +1 more source
Outcomes of polymyalgia rheumatica
In this study the outcomes of cases of patients diagnosed with polymyalgia rheumatica and treated in Kaunas Clinics of the Hospital of LUHS during the period of 2011-2015 were analysed. Data about 74 patients was collected from medical documentations and
Zobielienė, Dovilė
core
Steroid-sparing strategies in polymyalgia rheumatica: a systematic review and meta-analysis of tocilizumab with practical guidance for tapering. [PDF]
Bungish MK +12 more
europepmc +1 more source
Whole-body Dynamic [18F]FDG-PET/CT in Giant Cell Arteritis and Polymyalgia Rheumatica. [PDF]
Sah BR +11 more
europepmc +1 more source
Clinical Profile of Giant Cell Arteritis and Polymyalgia Rheumatica in a Tertiary Care Hospital in South India. [PDF]
George N A +4 more
europepmc +1 more source
Modern Management of Isolated Polymyalgia Rheumatica. [PDF]
Harkins P +6 more
europepmc +1 more source
Short-course prednisone and methotrexate in a cohort of patients with polymyalgia rheumatica: a potential therapeutic approach. [PDF]
Conticini E +7 more
europepmc +1 more source

